May 16, 2024
Adding atezolizumab to chemotherapy in patients with anti–programmed death ligand 1 (PD-L1)–positive triple-negative breast cancer (TNBC) who have relapsed within 12 months of their last curative […]
May 16, 2024
TOPLINE: In patients with localized pancreatic ductal adenocarcinoma (PDAC), failure to undergo resection following neoadjuvant chemotherapy is common and associated with worse survival. Researchers identified few […]
May 16, 2024
The US Food and Drug Administration has granted accelerated approval to lisocabtagene maraleucel (Breyanzi, Juno Therapeutics /Bristol Myers Squibb) for adults with relapsed or refractory follicular […]
May 15, 2024
While major guidelines support mammography for routine breast cancer screening in average-risk women, the decision to offer additional screening and which supplemental tool to use can […]
May 14, 2024
TOPLINE: Skipping standard axillary lymph node dissection led to very low rates of axillary recurrence in patients with node-positive breast cancer who became node-negative following neoadjuvant […]
May 14, 2024
As the Canadian Task Force on Preventive Health Care prepares to release its anticipated updated guidelines on breast cancer screening, University of Ottawa researchers are sounding […]
May 13, 2024
TOPLINE: A hypofractionated intensity-modulated radiotherapy (IMRT) may be safe and well-tolerated in women with cervical cancer undergoing pelvic irradiation with concurrent chemotherapy following surgical resection, results […]
May 13, 2024
(Reuters) -Merck said on Monday it had discontinued an experimental combination treatment testing a new type of immunotherapy in patients with a severe form of skin […]
May 10, 2024
TOPLINE: US counties with higher rates of prostate-specific antigen (PSA) screening have lower rates of advanced/metastatic prostate cancer and prostate cancer mortality in later years, a […]